These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6427304)

  • 21. Magnetic resonance imaging with gadolinium contrast agent in small deep (lacunar) cerebral infarcts.
    Regli L; Regli F; Maeder P; Bogousslavsky J
    Arch Neurol; 1993 Feb; 50(2):175-80. PubMed ID: 8431136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultraviolet and magnetic-circular-dichroic spectroscopic studies of Gd(III) complexed with diethylenetriaminepentaacetic acid. A contrast agent for NMR imaging.
    Bligh SW; Drake AF; Sadler PJ
    Eur J Biochem; 1989 Apr; 181(1):223-4. PubMed ID: 2714280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early experience of paramagnetic tracers in ultra low magnetic fields.
    Paajanen H
    Acta Radiol Suppl; 1990; 374():81-3. PubMed ID: 1966974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid MR imaging of renal perfusion: a comparative study of GdDTPA, albumin-(GdDTPA), and magnetite.
    Daly PF; Zimmerman JB; Gillen JS; Wolf GL
    Am J Physiol Imaging; 1989; 4(4):165-74. PubMed ID: 2696525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrast agents for magnetic resonance imaging.
    Wolf GL; Burnett KR; Goldstein EJ; Joseph PM
    Magn Reson Annu; 1985; ():231-66. PubMed ID: 3939977
    [No Abstract]   [Full Text] [Related]  

  • 26. Gadolinium-enhanced magnetic resonance imaging in multiple infarction.
    Yu YL
    Stroke; 1989 Feb; 20(2):299. PubMed ID: 2919419
    [No Abstract]   [Full Text] [Related]  

  • 27. Gadolinium-DTPA enhanced dynamic MR imaging in the evaluation of cisplatinum nephrotoxicity.
    Frank JA; Choyke PL; Girton ME; Austin HA; Sievenpiper C; Inscoe SW; Black JL; Carvlin MJ; Dwyer AJ
    J Comput Assist Tomogr; 1989; 13(3):448-59. PubMed ID: 2723175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contrast-enhanced MR imaging of the pancreas.
    Kettritz U; Semelka RC
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):87-100. PubMed ID: 8673719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paramagnetic contrast agents in magnetic resonance imaging: research at Vanderbilt University.
    Runge VM; Clanton JA; Price AC; Herzer WA; Wehr CJ; Lukehart CM; Partain CL; James AE
    Physiol Chem Phys Med NMR; 1984; 16(2):113-22. PubMed ID: 6438656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gadolinium-labeled liposomes: targeted MR contrast agents for the liver and spleen.
    Kabalka G; Buonocore E; Hubner K; Moss T; Norley N; Huang L
    Radiology; 1987 Apr; 163(1):255-8. PubMed ID: 3454163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pseudolayering of Gd-DTPA in the urinary bladder.
    Elster AD; Sobol WT; Hinson WH
    Radiology; 1990 Feb; 174(2):379-81. PubMed ID: 2296649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iron-based second-sphere contrast agents for magnetic resonance imaging: development of a model system and evaluation of iron (III) tris (tironate) complex in rats.
    Davies JA; Dutremez SG; Hockensmith CM; Keck R; Richardson N; Selman S; Smith DA; Ulmer CW; Wheatley LS; Zeiss J
    Acad Radiol; 1996 Nov; 3(11):936-45. PubMed ID: 8959184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic resonance imaging of acute myocardial infarction: gadolinium diethylenetriamine pentaacetic acid as a marker of reperfusion.
    Peshock RM; Malloy CR; Buja LM; Nunnally RL; Parkey RW; Willerson JT
    Circulation; 1986 Dec; 74(6):1434-40. PubMed ID: 3779924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gadolinium phosphonates as MR imaging contrast agents: physiologic effects in rabbit hearts.
    Adzamli IK; Weinstein H; Leppo JA
    J Magn Reson Imaging; 1993; 3(6):821-8. PubMed ID: 8280969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of regional cerebral blood volume in acute human stroke by use of single-slice dynamic susceptibility contrast-enhanced magnetic resonance imaging.
    Röther J; Gückel F; Neff W; Schwartz A; Hennerici M
    Stroke; 1996 Jun; 27(6):1088-93. PubMed ID: 8650719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benefits of Gd-DTPA for MR imaging of intracranial abnormalities.
    Hesselink JR; Healy ME; Press GA; Brahme FJ
    J Comput Assist Tomogr; 1988; 12(2):266-74. PubMed ID: 3351041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paramagnetic contrast media for magnetic resonance imaging of the mediastinum and lungs.
    Carr DH
    J Thorac Imaging; 1985 Dec; 1(1):74-8. PubMed ID: 3939639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the operating magnetic field on potential NMR contrast agents.
    Brown MA
    Magn Reson Imaging; 1985; 3(1):3-10. PubMed ID: 3923291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imaging of acute stroke.
    Bryan RN
    Radiology; 1990 Dec; 177(3):615-6. PubMed ID: 2243959
    [No Abstract]   [Full Text] [Related]  

  • 40. Gadolinium cryptelates as MR contrast agents.
    Knop RH; Frank JA; Dwyer AJ; Girton ME; Naegele M; Schrader M; Cobb J; Gansow O; Maegerstadt M; Brechbiel M
    J Comput Assist Tomogr; 1987; 11(1):35-42. PubMed ID: 3805426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.